Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present THC Biomed International Ltd. (OTC: THCBF).

Full DD Report for THCBF

You must become a subscriber to view this report.


Recent News from (OTC: THCBF)

Pot stocks perk up premarket
Cannabis stocks are showing some life premarket. Cronos Group (NASDAQ: CRON ) is up  24%  on robust volume, Canopy Growth (NYSE: CGC ) is up  7%  on increased volume and Tilray (NASDAQ: TLRY ) is up  11%  on average volume. More news on: Cronos Group, Inc., Ca...
Source: SeekingAlpha
Date: September, 05 2018 07:50
Citron bearish on Tilray due to valuation; shares up 9%
Citron Research, a buyer of pot stock Tilray ( TLRY +9.4% ) up to $45, is now bearish with a fair value target of $26, calling it "by far the most expensive in the space." The stock is currently exchanging hands at $72 up over four-fold from its IPO price of $17. More news on: Tilray, In...
Source: SeekingAlpha
Date: September, 04 2018 12:19
Profit-taking pressures Tilray, down 4% premarket
Tilray (NASDAQ: TLRY ) slips  4%  premarket on light volume as investors take money off the table after the stock's ~ 160%  run-up since touching $24 on August 14. More news on: Tilray, Inc., Canopy Growth Corporation, Cronos Group, Inc., Healthcare stocks news, Consumer sto...
Source: SeekingAlpha
Date: August, 30 2018 08:09
Beverage giants eye Canadian cannabis players
The large investment by Constellation Brands ( STZ +1.1% ) in Canopy Growth Corp. ( CGC +3.8% ) is still reverberating around the beverage industry as some of the larger names scramble to keep up. More news on: Constellation Brands, Inc., Canopy Growth Corporation, Anheuser-Busch InB...
Source: SeekingAlpha
Date: August, 29 2018 10:42
Weekly Cannabis Report: Diageo Fuels Speculation; Ontario Picks 26 Suppliers
Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary Last week, the Horizons Marijuana Life Sciences Index ETF ( OTC:HMLSF ) traded up a whopping 22% to end the week at C$20.24. The ...
Source: SeekingAlpha
Date: August, 27 2018 07:44
Diageo eyeing cannabis-infused beverages
Bloomberg reports that top alcohol producer Diageo Plc (NYSE: DEO ), aiming to boost growth and fend off competitors, is in discussions with at least three major Canadian producers to add cannabis-infused beverages to its portfolio. More news on: Diageo plc, Molson Coors Brewing Company,...
Source: SeekingAlpha
Date: August, 24 2018 07:26
U.S. pot market could be worth $47B - RBC #2
In a note , RBC Capital Markets says that legal sales of marijuana in the U.S. are catching up to beer and wine, potentially reaching $47B in ten years, implying a 17% CAGR. More news on: MJ Holdings, Inc., MyDx, Inc., Mountain High Acquisitions Corp., Healthcare stocks news, Consumer sto...
Source: SeekingAlpha
Date: August, 22 2018 09:55
Weed firms set for bullish action ahead of start of Canada recreational pot market
Cannabis-related stocks may see broad buying today as they announce supply agreements with retail operations ahead of the launch of the adult-use recreational cannabis market in Canada on October 17. Cronos Group (NASDAQ: CRON ) and Tilray (NASDAQ: TLRY ) have already announced deals. Both a...
Source: SeekingAlpha
Date: August, 21 2018 08:07
Tilray up 20% on Citron touch
"Today is the day that everything has changed in Cannabis," tweets Andrew Left . "Real $$$ into space. Next to get support should be Tilray ( TLRY +19.8% )." More news on: Tilray, Inc., Horizons Marijuana Life Sciences Index ETF, Cannimed Therapeutics Inc., Consumer stocks news, Healthc...
Source: SeekingAlpha
Date: August, 15 2018 12:59
InvestmentPitch Media Video Discusses THC BioMed's Development of a Cannabis Beverage that Mimics Alcohol - Video Available on InvestmentPitch.com
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2018) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHD), arguably Canada's largest supplier of legal Cannabis Genetics, has developed a cannabis beverage that mimics alcohol in that the uplifting and energizing effects of the cannabis ...
Source: Newsfile
Date: August, 10 2018 11:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-100.3276130.300.3420.3066,573
2018-12-070.3340.34090.34090.3182320,962
2018-12-060.3130.32850.330.2957,287
2018-12-050.350.350.35340.31394117,140
2018-12-040.350.350.35340.31394117,140

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1016,01166,57324.0503Cover
2018-12-074,01520,56219.5263Cover
2018-12-069,98057,28717.4211Cover
2018-12-0417,150115,14014.8949Cover
2018-12-037,02829,67123.6864Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on THCBF.


About THC Biomed International Ltd. (OTC: THCBF)

Logo for THC Biomed International Ltd. (OTC: THCBF)

THC BioMed is a Canadian federally Licensed Producer and Canada s largest supplier of legal Cannabis Genetics. THC also produces and sells dried and fresh marihuana and cannabis oil for medical purposes. Strategically located in Kelowna, British Columbia, Canada, THC is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. The list of Health Canada licensed producers can be found at http://www.hc sc.gc.ca/dhp mps/marihuana/info/list eng.php

 

Contact Information

 

 

Current Management

  • John Miller / CEO, President
  • Hee Jung Chun / CFO
  • Hee Jung Chun /
  • John Miller / Audit Committee Member

Current Share Structure

  • Market Cap: $155,969,220 - 03/16/2018
  • Issue and Outstanding: 116,394,940 - 03/15/2018

 


Recent Filings from (OTC: THCBF)

OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: March, 15 2018
Supplemental Information - Supplemental Information
Filing Type: Supplemental Information - Supplemental InformationFiling Source: OTC Markets
Filing Date: January, 08 2018
Supplemental Information - Supplemental Information
Filing Type: Supplemental Information - Supplemental InformationFiling Source: OTC Markets
Filing Date: January, 08 2018
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: January, 08 2018
Interim Financial Report - Interim Financial Report
Filing Type: Interim Financial Report - Interim Financial ReportFiling Source: OTC Markets
Filing Date: January, 08 2018
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: November, 28 2017
Annual Report - THC Audited Annual Financial Statements for Year Ended July 31, 2017
Filing Type: Annual Report - THC Audited Annual Financial Statements for Year Ended July 31, 2017Filing Source: OTC Markets
Filing Date: November, 28 2017

 

 


Daily Technical Chart for (OTC: THCBF)

Daily Technical Chart for (OTC: THCBF)


Stay tuned for daily updates and more on (OTC: THCBF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: THCBF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in THCBF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of THCBF and does not buy, sell, or trade any shares of THCBF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/